The Valley Desk

ArticleBritish journal of haematologyPublished

Oral azacitidine modulates the bone marrow microenvironment in patients with acute myeloid leukaemia in remission: A subanalysis from the QUAZAR AML-001 trial

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

Publication record

Type
Article
Venue
British journal of haematology
Published
Subject terms
Bone Marrow; Humans; Neoplasm Recurrence, Local; Azacitidine; Antimetabolites, Antineoplastic; Antigens, CD34; Antimetabolites; Leukemia, Myeloid, Acute; Tumor Microenvironment; T cells; AMl; Chemotherapy
PubMed ID
36990798
Added to directory
Source checked

Report a correction or request removal